Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, pathways, authors, ontology terms, etc. (e.g. eve, embryo, zen, allele)
  • Use OR to search for either of two terms (e.g. fly OR drosophila) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. dros* for partial matches or fly AND NOT embryo to exclude a term

Search results 4301 to 4400 out of 44733 for *

Category restricted to GOTerm (x)

<< First    < Previous  |  Next >    Last >>
0.014s

Categories

Category: GOTerm
« show all
Type Details Score
GO Term
GO:0061082 | myeloid leukocyte cytokine production
Description: Any process that contributes to cytokine production by a myeloid cell.
•
•
•
•
•
GO Term
GO:0002373 | plasmacytoid dendritic cell cytokine production
Description: Any process that contributes to cytokine production by a plasmacytoid dendritic cell.
•
•
•
•
•
GO Term
GO:0002374 | cytokine secretion involved in immune response
Description: The regulated release of cytokines from a cell that contributes to an immune response.
•
•
•
•
•
GO Term
GO:0050663 | cytokine secretion
Description: The regulated release of cytokines from a cell. Cytokines are any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
•
•
•
•
•
GO Term
GO:0042089 | cytokine biosynthetic process
Description: The chemical reactions and pathways resulting in the formation of cytokines, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
•
•
•
•
•
GO Term
GO:0002375 | cytokine biosynthetic process involved in immune response
Description: The chemical reactions and pathways resulting in the formation of a cytokine that contributes to an immune response.
•
•
•
•
•
GO Term
GO:0042107 | cytokine metabolic process
Description: The chemical reactions and pathways involving cytokines, any of a group of proteins or glycoproteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
•
•
•
•
•
GO Term
GO:0002378 | immunoglobulin biosynthetic process
Description: The chemical reactions and pathways resulting in the formation of immunoglobulin.
•
•
•
•
•
GO Term
GO:0002379 | immunoglobulin biosynthetic process involved in immune response
Description: The chemical reactions and pathways resulting in the formation of immunoglobulin contributing to an immune response.
•
•
•
•
•
GO Term
GO:0048305 | immunoglobulin secretion
Description: The regulated release of immunoglobulins from a B cell or plasma cell, whose mechanism includes the use of alternate polyadenylylation signals to favor the biosynthesis of secreted forms of immunoglobulin over membrane-bound immunoglobulin.
•
•
•
•
•
GO Term
GO:0002380 | immunoglobulin secretion involved in immune response
Description: The regulated release of immunoglobulins from a B cell or plasma cell contributing to an immune response.
•
•
•
•
•
GO Term
GO:0002382 | regulation of tissue kallikrein-kinin cascade
Description: Any process that modulates the frequency, rate, or extent of the tissue kallikrein-kinin cascade.
•
•
•
•
•
GO Term
GO:0002383 | immune response in brain or nervous system
Description: An immune response taking place in the brain or nervous system.
•
•
•
•
•
GO Term
GO:0002384 | hepatic immune response
Description: An immune response taking place in the liver.
•
•
•
•
•
GO Term
GO:0002386 | immune response in mucosal-associated lymphoid tissue
Description: Immune response taking place in the mucosal-associated lymphoid tissue (MALT). Mucosal-associated lymphoid tissue is typically found as nodules associated with mucosal epithelia with distinct internal structures including B- and T-zones for the activation of lymphocytes.
•
•
•
•
•
GO Term
GO:0002387 | immune response in gut-associated lymphoid tissue
Description: Immune response taking place in the gut-associated lymphoid tissue (GALT). GALT includes Peyer's patches, appendix, and solitary lymph nodules.
•
•
•
•
•
GO Term
GO:0002388 | immune response in Peyer's patch
Description: Immune response taking place in the Peyer's patch, nodular lymphoid structures on the serosal surface of the small intestine.
•
•
•
•
•
GO Term
GO:0002389 | tolerance induction in Peyer's patch
Description: Tolerance induction taking place in the Peyer's patches.
•
•
•
•
•
GO Term
GO:0002394 | tolerance induction in gut-associated lymphoid tissue
Description: Tolerance induction taking place in the gut-associated lymphoid tissue (GALT).
•
•
•
•
•
GO Term
GO:0002401 | tolerance induction in mucosal-associated lymphoid tissue
Description: Tolerance induction taking place in the mucosal-associated lymphoid tissue (MALT).
•
•
•
•
•
GO Term
GO:0002427 | mucosal tolerance induction
Description: Tolerance induction taking place in the mucosal tissues.
•
•
•
•
•
GO Term
GO:0002461 | tolerance induction dependent upon immune response
Description: Tolerance induction dependent upon an immune response, typically a response by a mature T or B cell in the periphery resulting tolerance towards an antigen via induction of anergy, cellular deletion, or regulatory T cell activation.
•
•
•
•
•
GO Term
GO:0002462 | tolerance induction to nonself antigen
Description: Tolerance induction in response to nonself antigens.
•
•
•
•
•
GO Term
GO:0002390 | platelet activating factor production
Description: The synthesis or release of platelet activating factor following a stimulus, resulting in an increase in its intracellular or extracellular levels.
•
•
•
•
•
GO Term
GO:0002391 | platelet activating factor production involved in inflammatory response
Description: The synthesis or release of platelet activating factor following a stimulus as part of an inflammatory response, resulting in an increase in its intracellular or extracellular levels.
•
•
•
•
•
GO Term
GO:0002534 | cytokine production involved in inflammatory response
Description: The synthesis or release of a cytokine following a inflammatory stimulus as part of an inflammatory response, resulting in an increase in its intracellular or extracellular levels.
•
•
•
•
•
GO Term
GO:0002392 | platelet activating factor secretion
Description: The regulated release of platelet activating factor by a cell.
•
•
•
•
•
GO Term
GO:0002393 | lysosomal enzyme production involved in inflammatory response
Description: The synthesis or release of lysosomal enzymes following a stimulus as part of a inflammatory response, resulting in an increase in intracellular or extracellular levels.
•
•
•
•
•
GO Term
GO:0002395 | immune response in nasopharyngeal-associated lymphoid tissue
Description: An immune response taking place in the nasopharyngeal-associated lymphoid tissue (NALT). NALT includes the tonsils and adenoids.
•
•
•
•
•
GO Term
GO:0002396 | MHC protein complex assembly
Description: The aggregation, arrangement and bonding together of a set of components to form an MHC protein complex.
•
•
•
•
•
GO Term
GO:0002397 | MHC class I protein complex assembly
Description: The aggregation, arrangement and bonding together of a set of components to form an MHC class I protein complex. Class I here refers to classical class I molecules.
•
•
•
•
•
GO Term
GO:0002398 | MHC class Ib protein complex assembly
Description: The aggregation, arrangement and bonding together of a set of components to form an MHC class Ib protein complex. Class Ib here refers to non-classical class I molecules.
•
•
•
•
•
GO Term
GO:0002399 | MHC class II protein complex assembly
Description: The aggregation, arrangement and bonding together of a set of components to form an MHC class II protein complex.
•
•
•
•
•
GO Term
GO:0002400 | tolerance induction in nasopharyngeal-associated lymphoid tissue
Description: Tolerance induction taking place in the nasopharyngeal-associated lymphoid tissue (NALT).
•
•
•
•
•
GO Term
GO:0002451 | peripheral B cell tolerance induction
Description: Tolerance induction of mature B cells in the peripheral lymphoid tissues: the blood, lymph nodes, spleen, and mucosal-associated lymphoid tissue.
•
•
•
•
•
GO Term
GO:0002402 | B cell tolerance induction in mucosal-associated lymphoid tissue
Description: Tolerance induction taking place in the mucosal-associated lymphoid tissue (MALT) mediated by B cells.
•
•
•
•
•
GO Term
GO:0002465 | peripheral tolerance induction
Description: Tolerance induction in the peripheral lymphoid tissues: blood, lymph nodes, spleen, and mucosal-associated lymphoid tissues.
•
•
•
•
•
GO Term
GO:0002458 | peripheral T cell tolerance induction
Description: Tolerance induction of T cells in the periphery, in this case, any location in the body other than the thymus.
•
•
•
•
•
GO Term
GO:0002403 | T cell tolerance induction in mucosal-associated lymphoid tissue
Description: Tolerance induction taking place in the mucosal-associated lymphoid tissue (MALT) mediated by T cells.
•
•
•
•
•
GO Term
GO:0002517 | T cell tolerance induction
Description: A process involving any mechanism for tolerance induction in T cells.
•
•
•
•
•
GO Term
GO:0002404 | antigen sampling in mucosal-associated lymphoid tissue
Description: The process of apical-to-basolateral delivery of soluble and particulate antigens to underlying mucosal-associated lymphoid tissue.
•
•
•
•
•
GO Term
GO:0002405 | antigen sampling by dendritic cells in mucosal-associated lymphoid tissue
Description: The process of antigen sampling carried out by dendritic cells in the mucosal-associated lymphoid tissue.
•
•
•
•
•
GO Term
GO:0002468 | dendritic cell antigen processing and presentation
Description: The process in which a dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
•
•
•
•
•
GO Term
GO:0002406 | antigen sampling by M cells in mucosal-associated lymphoid tissue
Description: The process of antigen samples carried out by M cells in the mucosal-associated lymphoid tissue.
•
•
•
•
•
GO Term
GO:0036336 | dendritic cell migration
Description: The movement of a dendritic cell within or between different tissues and organs of the body.
•
•
•
•
•
GO Term
GO:0002407 | dendritic cell chemotaxis
Description: The movement of a dendritic cell in response to an external stimulus.
•
•
•
•
•
GO Term
GO:0002408 | myeloid dendritic cell chemotaxis
Description: The movement of a myeloid dendritic cell in response to an external stimulus.
•
•
•
•
•
GO Term
GO:0002409 | Langerhans cell chemotaxis
Description: The movement of a Langerhans cell in response to an external stimulus.
•
•
•
•
•
GO Term
GO:0002410 | plasmacytoid dendritic cell chemotaxis
Description: The movement of a plasmacytoid dendritic cell in response to an external stimulus.
•
•
•
•
•
GO Term
GO:0002424 | T cell mediated immune response to tumor cell
Description: An immune response mediated by a T cell triggered in response to the presence of a tumor cell.
•
•
•
•
•
GO Term
GO:0002411 | T cell tolerance induction to tumor cell
Description: A process of tolerance induction dependent on T cells which leads to immunological tolerance of a tumor.
•
•
•
•
•
GO Term
GO:0002413 | tolerance induction to tumor cell
Description: A process of tolerance induction which leads to immunological tolerance of a tumor.
•
•
•
•
•
GO Term
GO:0002418 | immune response to tumor cell
Description: An immune system process that functions in the response of an organism to a tumor cell.
•
•
•
•
•
GO Term
GO:0002412 | antigen transcytosis by M cells in mucosal-associated lymphoid tissue
Description: The process of antigen transcytosis carried out by M cells in the mucosal-associated lymphoid tissue (MALT). Transcytosis is the process of the directed movement of endocytosed material through the cell and its exocytosis from the plasma membrane at the opposite side. M cells are specialized epithelia cells with a microfold structure that are adept at moving antigens from the gut lumen to antigen presenting cells in the MALT.
•
•
•
•
•
GO Term
GO:0045056 | transcytosis
Description: The directed movement of endocytosed material through the cell and its exocytosis from the plasma membrane at the opposite side.
•
•
•
•
•
GO Term
GO:0002414 | immunoglobulin transcytosis in epithelial cells
Description: The process of transporting immunoglobulin, via transcytosis, from one side of an epithelial cell to the other.
•
•
•
•
•
GO Term
GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor
Description: The process of transporting polymeric IgA and polymeric IgM immunoglobulin, via transcytosis mediated by the polymeric immunoglobulin receptor (pIgR), from the basolateral surface to apical surface of an epithelial cell. At the apical surface the immunoglobulin binding portion of the pIgRis cleaved and remains bound to the transported immunoglobulin as secretory component (SC). The same process is used for the transport and excretion of IgA immune complexes to the luminal surface of the mucosa.
•
•
•
•
•
GO Term
GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor
Description: The process of transporting IgG immunoglobulin, via transcytosis using the FcRn (also known as the neonatal Fc receptor; gene name FCGRT), from apical surface of an epithelial cell to the basolateral surface or vice versa depending on the location. This process is used for uptake of IgG from the milk in the gut in rodents, for transplacental transport of IgG from mother to embryo in humans, and for maintenance of a steady-state distribution of IgG across epithelial boundaries in general in adult mammals.
•
•
•
•
•
GO Term
GO:0002751 | antigen processing and presentation following receptor mediated endocytosis
Description: Antigen processing and presentation which is initiated by uptake of antigen receptor-mediated endocytosis.
•
•
•
•
•
GO Term
GO:0002417 | B cell antigen processing and presentation mediated by B cell receptor uptake of antigen
Description: B cell antigen processing and presentation which is initiated by uptake of antigen bound to the B cell receptor.
•
•
•
•
•
GO Term
GO:0002450 | B cell antigen processing and presentation
Description: The process in which a B cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
•
•
•
•
•
GO Term
GO:0002745 | antigen processing and presentation initiated by receptor mediated uptake of antigen
Description: Antigen processing and presentation which is initiated by uptake of antigen bound to a cell surface receptor.
•
•
•
•
•
GO Term
GO:0002419 | T cell mediated cytotoxicity directed against tumor cell target
Description: The directed killing of a tumor cell by a T cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors.
•
•
•
•
•
GO Term
GO:0002423 | natural killer cell mediated immune response to tumor cell
Description: An immune response mediated by a natural killer cell triggered in response to the presence of a tumor cell.
•
•
•
•
•
GO Term
GO:0002420 | natural killer cell mediated cytotoxicity directed against tumor cell target
Description: The directed killing of a tumor cell by a natural killer cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors.
•
•
•
•
•
GO Term
GO:0042267 | natural killer cell mediated cytotoxicity
Description: The directed killing of a target cell by a natural killer cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors.
•
•
•
•
•
GO Term
GO:0002421 | B cell antigen processing and presentation following pinocytosis
Description: B cell antigen processing and presentation which is initiated by uptake of antigen via pinocytosis.
•
•
•
•
•
GO Term
GO:0002746 | antigen processing and presentation following pinocytosis
Description: Antigen processing and presentation which is initiated by uptake of antigen via pinocytosis.
•
•
•
•
•
GO Term
GO:0002422 | immune response in urogenital tract
Description: An immune response taking place in the urogenital tract. The urogenital tract.
•
•
•
•
•
GO Term
GO:0002425 | tolerance induction in urogenital tract
Description: Tolerance induction taking place in the urogenital tract.
•
•
•
•
•
GO Term
GO:0002426 | immunoglobulin production in mucosal tissue
Description: The synthesis and release of immunoglobulin in the mucosal tissue.
•
•
•
•
•
GO Term
GO:0002475 | antigen processing and presentation via MHC class Ib
Description: The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC class Ib protein complex. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families.
•
•
•
•
•
GO Term
GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib
Description: The process in which an antigen-presenting cell expresses peptide antigen in association with an MHC class Ib protein complex on its cell surface. The peptide antigen may originate from an endogenous or exogenous protein. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E family.
•
•
•
•
•
GO Term
GO:0002430 | complement receptor mediated signaling pathway
Description: A series of molecular signals generated as a consequence of a component of the complement pathway binding to a complement receptor. Such components include both whole complement proteins and fragments of complement proteins generated through the activity of the complement pathway.
•
•
•
•
•
GO Term
GO:0002431 | Fc receptor mediated stimulatory signaling pathway
Description: A series of molecular signals generated as a consequence of a the binding of the Fc portion of an immunoglobulin by an Fc receptor capable of activating or perpetuating an immune response. The Fc portion of an immunoglobulin is its C-terminal constant region.
•
•
•
•
•
GO Term
GO:0002432 | granuloma formation
Description: The formation of nodular inflammatory lesions, usually small or granular, firm, persistent, well-structured, and containing compactly grouped T lymphocytes and modified phagocytes such as epithelioid cells, giant cells, and other macrophages. Granuloma formation represents a chronic inflammatory response initiated by various infectious and noninfectious agents. The center of a granuloma consists of fused macrophages, which can become necrotic.
•
•
•
•
•
GO Term
GO:0002544 | chronic inflammatory response
Description: Inflammation of prolonged duration (weeks or months) in which active inflammation, tissue destruction, and attempts at repair are proceeding simultaneously. Although it may follow acute inflammation, chronic inflammation frequently begins insidiously, as a low-grade, smoldering, often asymptomatic response.
•
•
•
•
•
GO Term
GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis
Description: An immune response-regulating cell surface receptor signaling pathway that contributes to the endocytic engulfment of external particulate material by phagocytes.
•
•
•
•
•
GO Term
GO:0002434 | immune complex clearance
Description: A process directed at removing immune complexes from the body. Immune complexes are clusters of antibodies bound to antigen, to which complement may also be fixed, and which may precipitate or remain in solution.
•
•
•
•
•
GO Term
GO:0002435 | immune complex clearance by erythrocytes
Description: The process of immune complex clearance by erythrocytes.
•
•
•
•
•
GO Term
GO:0002436 | immune complex clearance by monocytes and macrophages
Description: The process of immune complex clearance by monocytes or macrophages.
•
•
•
•
•
GO Term
GO:0002439 | chronic inflammatory response to antigenic stimulus
Description: A chronic inflammatory response to an antigenic stimulus. A chronic inflammatory response persists indefinitely during days, weeks, or months in the life of an individual.
•
•
•
•
•
GO Term
GO:0002441 | histamine secretion involved in inflammatory response
Description: The regulated release of histamine by a cell as part of an inflammatory response.
•
•
•
•
•
GO Term
GO:0002442 | serotonin secretion involved in inflammatory response
Description: The regulated release of serotonin by a cell as part of an inflammatory response.
•
•
•
•
•
GO Term
GO:0002446 | neutrophil mediated immunity
Description: Any process involved in the carrying out of an immune response by a neutrophil.
•
•
•
•
•
GO Term
GO:0002447 | eosinophil mediated immunity
Description: Any process involved in the carrying out of an immune response by an eosinophil.
•
•
•
•
•
GO Term
GO:0002448 | mast cell mediated immunity
Description: Any process involved in the carrying out of an immune response by a mast cell.
•
•
•
•
•
GO Term
GO:0002453 | peripheral B cell anergy
Description: Any process contributing to anergy, a state of functional inactivation that occurs as part of tolerance induction, in peripheral B cells.
•
•
•
•
•
GO Term
GO:0002454 | peripheral B cell deletion
Description: The deletion of B cells by apoptotic process occurring as part of peripheral tolerance induction and B cell selection.
•
•
•
•
•
GO Term
GO:0002455 | humoral immune response mediated by circulating immunoglobulin
Description: An immune response dependent upon secreted immunoglobulin. An example of this process is found in Mus musculus.
•
•
•
•
•
GO Term
GO:0002457 | T cell antigen processing and presentation
Description: The process in which a T cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
•
•
•
•
•
GO Term
GO:0002459 | adaptive immune response based on somatic recombination of immune receptors built from leucine-rich repeat domains
Description: An immune response mediated by lymphocytes expressing specific receptors for antigen produced through a somatic diversification process that includes somatic recombination of variable lymphocyte receptors (VLR) incorporating leucine-rich repeat (LRR) domains, and allowing for enhanced responses upon subsequent exposures to the same antigen (immunological memory). Examples of this process are found in jawless fish, including the lampreys (Petromyzontidae) and hagfishes (Myxinidae).
•
•
•
•
•
GO Term
GO:0002463 | central tolerance induction to nonself antigen
Description: Tolerance induction to nonself antigens in the central lymphoid organs.
•
•
•
•
•
GO Term
GO:0002464 | peripheral tolerance induction to nonself antigen
Description: Tolerance induction to nonself antigens in the periphery.
•
•
•
•
•
GO Term
GO:0002513 | tolerance induction to self antigen
Description: Tolerance induction directed at self antigens.
•
•
•
•
•
GO Term
GO:0002466 | peripheral tolerance induction to self antigen
Description: Tolerance induction to self antigens in the peripheral lymphoid tissues: blood, lymph nodes, spleen, and mucosal-associated lymphoid tissues.
•
•
•
•
•
GO Term
GO:0002469 | myeloid dendritic cell antigen processing and presentation
Description: The process in which a myeloid dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
•
•
•
•
•
GO Term
GO:0002470 | plasmacytoid dendritic cell antigen processing and presentation
Description: The process in which a plasmacytoid dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
•
•
•
•
•
GO Term
GO:0002471 | monocyte antigen processing and presentation
Description: The process in which a monocyte expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
•
•
•
•
•
GO Term
GO:0002472 | macrophage antigen processing and presentation
Description: The process in which a macrophage expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
•
•
•
•
•
USDA
InterMine logo
The Legume Information System (LIS) is a research project of the USDA-ARS:Corn Insects and Crop Genetics Research in Ames, IA.
LegumeMine || ArachisMine | CicerMine | GlycineMine | LensMine | LupinusMine | PhaseolusMine | VignaMine | MedicagoMine
InterMine © 2002 - 2022 Department of Genetics, University of Cambridge, Downing Street, Cambridge CB2 3EH, United Kingdom